These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10717009)

  • 21. [Uncomplicated acute myocardial infarction -- when should the patient be discharged?].
    Ribeiro A; Moura P; Azevedo L; Ferrão B; Marques A; Lopes MA
    Rev Port Cardiol; 2001 Nov; 20(11):1103-6. PubMed ID: 11826701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
    Barbagelata A; Califf RM; Sgarbossa EB; Knight D; Mark DB; Granger CB; Armstrong PW; Elizari M; Birnbaum Y; Grinfeld LR; Ohman EM; Wagner GS;
    Am Heart J; 2004 Nov; 148(5):795-802. PubMed ID: 15523309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention.
    Cowper PA; Udayakumar K; Sketch MH; Peterson ED
    J Am Coll Cardiol; 2005 Feb; 45(3):369-76. PubMed ID: 15680714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge.
    De Luca G; Suryapranata H; van 't Hof AW; de Boer MJ; Hoorntje JC; Dambrink JH; Gosselink AT; Ottervanger JP; Zijlstra F
    Circulation; 2004 Jun; 109(22):2737-43. PubMed ID: 15159293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Socioeconomic implications of the practice of thrombolysis in the acute stage of myocardial infarction].
    Herve C; Castiel D; Gaillard M; Daussac C; Leroux V; Jan F; Castaigne A
    Arch Mal Coeur Vaiss; 1989 Mar; 82(3):353-8. PubMed ID: 2502091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
    Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
    Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health system costs of out-of-hospital cardiac arrest in relation to time to shock.
    van Alem AP; Dijkgraaf MG; Tijssen JG; Koster RW
    Circulation; 2004 Oct; 110(14):1967-73. PubMed ID: 15381641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of therapeutic hypothermia after cardiac arrest.
    Merchant RM; Becker LB; Abella BS; Asch DA; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):421-8. PubMed ID: 20031872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pathways--an evaluation of its impact on the quality of care in an acute care general hospital in Singapore.
    Cheah J
    Singapore Med J; 2000 Jul; 41(7):335-46. PubMed ID: 11026801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
    Mahoney EM; Mehta S; Yuan Y; Jackson J; Chen R; Gabriel S; Lamy A; Culler S; Caro J; Yusuf S; Weintraub WS;
    Am Heart J; 2006 Jan; 151(1):219-27. PubMed ID: 16368322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion.
    Topol EJ; Burek K; O'Neill WW; Kewman DG; Kander NH; Shea MJ; Schork MA; Kirscht J; Juni JE; Pitt B
    N Engl J Med; 1988 Apr; 318(17):1083-8. PubMed ID: 3281014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
    Eastwood GL
    N Engl J Med; 2000 Aug; 343(9):658. PubMed ID: 10979799
    [No Abstract]   [Full Text] [Related]  

  • 33. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.
    Goldman L; Sia ST; Cook EF; Rutherford JD; Weinstein MC
    N Engl J Med; 1988 Jul; 319(3):152-7. PubMed ID: 2898733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.
    Newby LK; Califf RM; Guerci A; Weaver WD; Col J; Horgan JH; Mark DB; Stebbins A; Van de Werf F; Gore JM; Topol EJ
    J Am Coll Cardiol; 1996 Mar; 27(3):625-32. PubMed ID: 8606274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
    Kalish SC; Gurwitz JH; Krumholz HM; Avorn J
    J Gen Intern Med; 1995 Jun; 10(6):321-30. PubMed ID: 7562123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic model.
    Vale L; Steffens H; Donaldson C
    Pharmacoeconomics; 2004; 22(14):943-54. PubMed ID: 15362930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital discharge one week after acute myocardial infarction.
    McNeer JF; Wagner GS; Ginsburg PB; Wallace AG; McCants CB; Conley MJ; Rosati RA
    N Engl J Med; 1978 Feb; 298(5):229-32. PubMed ID: 413039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.
    van Klaveren D; Wong JB; Kent DM; Steyerberg EW
    Med Decis Making; 2017 Oct; 37(7):770-778. PubMed ID: 28854143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
    Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
    Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.